Autosomal dominant cerebellar ataxia
MONDO:0020380A clinically and genetically heterogeneous group of neurodegenerative diseases characterized by a slowly progressive ataxia of gait, stance and limbs, dysarthria and/or oculomotor disorder, due to cerebellar degeneration in the absence of coexisting diseases. The degenerative process can be limited to the cerebellum (ADCA type 3) or may additionally involve the retina (ADCA type 2), optic nerve, ponto-medullary systems, basal ganglia, cerebral cortex, spinal tracts or peripheral nerves (ADCA type 1). In ACDA type 4, a cerebellar syndrome is associated with epilepsy.
Also known as: SCA, spinocerebellar ataxia, ADCA, Autosomal Dominant Hereditary Ataxia, autosomal dominant spinocerebellar ataxia, cerebellar ataxia, autosomal dominant, Pierre Marie cerebellar ataxia (formerly)
50 clinical trials for this condition and its sub-types, 11 tagged with Autosomal dominant cerebellar ataxia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Autosomal dominant cerebellar ataxia
-
Autosomal dominant cerebellar ataxia type I 0 trials · 16 incl. sub-types
30 sub-types
- Machado-Joseph disease 11 trials Sub-types →
- Spinocerebellar ataxia type 1 10 trials
- Spinocerebellar ataxia type 2 10 trials Sub-types →
- Spinocerebellar ataxia type 8 4 trials
- Spinocerebellar ataxia type 27 2 trials
- Spinocerebellar ataxia type 23 1 trial
- Spinocerebellar ataxia type 29 1 trial
- Autosomal dominant cerebellar ataxia, deafness and narcolepsy 0 trials
- Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 0 trials
- Cerebellar dysfunction with variable cognitive and behavioral abnormalities 0 trials
- Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism 0 trials
- Spinocerebellar ataxia 46 0 trials
- Spinocerebellar ataxia type 12 0 trials
- Spinocerebellar ataxia type 13 0 trials
- Spinocerebellar ataxia type 14 0 trials
- Spinocerebellar ataxia type 15/16 0 trials
- Spinocerebellar ataxia type 17 0 trials
- Spinocerebellar ataxia type 18 0 trials
- Spinocerebellar ataxia type 19/22 0 trials
- Spinocerebellar ataxia type 20 0 trials
- Spinocerebellar ataxia type 21 0 trials
- Spinocerebellar ataxia type 25 0 trials
- Spinocerebellar ataxia type 28 0 trials
- Spinocerebellar ataxia type 32 0 trials
- Spinocerebellar ataxia type 34 0 trials
- Spinocerebellar ataxia type 35 0 trials
- Spinocerebellar ataxia type 36 0 trials
- Spinocerebellar ataxia type 37 0 trials
- Spinocerebellar ataxia type 4 0 trials
- Spinocerebellar ataxia type 40 0 trials
-
Autosomal dominant cerebellar ataxia type III 0 trials · 9 incl. sub-types
10 sub-types
- Spinocerebellar ataxia type 6 9 trials
- Spinocerebellar ataxia 45 0 trials
- Spinocerebellar ataxia type 11 0 trials
- Spinocerebellar ataxia type 26 0 trials
- Spinocerebellar ataxia type 30 0 trials
- Spinocerebellar ataxia type 31 0 trials
- Spinocerebellar ataxia type 38 0 trials
- Spinocerebellar ataxia type 41 0 trials
- Spinocerebellar ataxia type 42 0 trials Sub-types →
- Spinocerebellar ataxia type 5 0 trials
-
Autosomal dominant cerebellar ataxia type IV 0 trials · 8 incl. sub-types
2 sub-types
- Dentatorubral-pallidoluysian atrophy 4 trials
- Spinocerebellar ataxia type 10 4 trials
-
Spinocerebellar ataxia 7 7 trials
-
Spinocerebellar ataxia 9 2 trials
-
Spinocerebellar ataxia 27A 1 trial
-
Spinocerebellar ataxia 43 0 trials
-
Spinocerebellar ataxia 44 0 trials
-
Spinocerebellar ataxia 47 0 trials
-
Spinocerebellar ataxia 48 0 trials
-
Spinocerebellar ataxia 49 0 trials
-
Spinocerebellar ataxia 50 0 trials
-
Spinocerebellar ataxia 51 0 trials
Most studied deeper sub-types
-
Hope for ataxia: experimental drug shows promise in Late-Stage trial
Disease control CompletedThis study tested a drug called troriluzole in 141 adults with spinocerebellar ataxia, a rare disease that affects balance and coordination. Participants took either the drug or a placebo daily for 8 weeks. The main goal was to see if troriluzole could improve symptoms like walki…
Phase 2/3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New blood test could replace risky prenatal procedures for genetic diseases
Diagnosis CompletedThis study aimed to develop a non-invasive prenatal test using fetal cells from a mother's blood to detect triplet repeat diseases like Huntington's disease, Fragile X syndrome, and certain types of muscular dystrophy and ataxia. Researchers enrolled 60 pregnant women at risk and…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Brain study sheds light on Parkinson's and tics
Knowledge-focused CompletedThis completed study from the National Institute of Neurological Disorders and Stroke aimed to better understand how the brain controls movement and what goes wrong in movement disorders like Parkinson's disease, Tourette's syndrome, and dystonia. Over 1,200 adults—both patients …
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Hunting for the first clues of a devastating brain disease
Knowledge-focused CompletedThis study follows people who have a 50% chance of inheriting a gene for spinocerebellar ataxia, a group of progressive brain disorders that affect movement and coordination. The goal is to identify the earliest clinical signs and biological markers that appear before the disease…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Brain scan and spinal tap study aims to speed up ataxia drug trials
Knowledge-focused CompletedThis completed study looked at 40 people with spinocerebellar ataxia types 2 and 7, a rare brain disease that affects movement. Researchers used MRI scans and lumbar punctures over one year to track changes in the brain and body. The goal was to find reliable markers that could b…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Wrist-Worn gadget could help doctors monitor Parkinson's at home
Knowledge-focused CompletedThis study tested a wrist-worn device called the Personal KinetiGraph (PKG) to see if it can accurately measure movement problems in people with Parkinson's disease. Nineteen participants wore the device while researchers compared its readings to standard clinical tests and video…
Sponsor: Global Kinetics Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC